PTH and Marchiafava-Bignami disease: The Kidney Disease Improving Global Outcomes (KDIGO) Clinical Practice Guidelines for chronic kidney disease–mineral and bone disorder (CKD-MBD) suggested that the reasonable frequency for evaluating these parameters is every 1–3 months for Ca and P and every 3–6 months for PTH, although the evidence level was “Not Graded” [11].